These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32634569)

  • 1. Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs.
    Van Ngo H; Park C; Tran TTD; Nguyen VH; Lee BJ
    Eur J Pharm Biopharm; 2020 Sep; 154():8-17. PubMed ID: 32634569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic molecular effect of differently charged surfactants on the solubilization capacity and physicochemical properties of salt-caged nanosuspensions containing pH-dependent and poorly water-soluble rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Lee BJ
    Int J Pharm; 2022 May; 619():121686. PubMed ID: 35314274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
    Tran CTM; Tran PHL; Tran TTD
    Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of a fattigation platform gelatin-oleic acid sodium salt conjugate as a novel solubilizing adjuvant for poorly water-soluble drugs via self-assembly and nanonization.
    Kim D; Park C; Meghani NM; Tran TTD; Tran PHL; Park JB; Lee BJ
    Int J Pharm; 2020 Feb; 575():118892. PubMed ID: 31786354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan.
    Ha NS; Tran TT; Tran PH; Park JB; Lee BJ
    Chem Pharm Bull (Tokyo); 2011; 59(7):844-50. PubMed ID: 21720034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid-base neutralization approach.
    Chougule M; Sirvi A; Saini V; Kashyap M; Sangamwar AT
    Drug Deliv Transl Res; 2023 Oct; 13(10):2503-2519. PubMed ID: 37024611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability.
    Vuppalapati L; Cherukuri S; Neeli V; Yeragamreddy PR; Kesavan BR
    Curr Drug Deliv; 2016; 13(1):143-57. PubMed ID: 26205900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
    Tran TT; Tran PH; Lee BJ
    Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study.
    Gora S; Mustafa G; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2016; 23(3):940-50. PubMed ID: 24937379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
    Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B
    Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
    Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
    Kenechukwu FC; Dias ML; Ricci-Júnior E
    Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
    Dugar RP; Gajera BY; Dave RH
    AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
    Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y
    Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.